-transparent.png){kind=logo}
Atherosclerosis is a disease which develops very gradually over decades. Under the influence of modifiable cardiovascular risk factors, such as blood pressure, LDL-cholesterol level, smoking or lifestyle, clinical symptoms of atherosclerosis manifest more or less early in life. When cardiovascular risk factors accumulate, the risk of having a cardiovascular event increases and the benefits of prevention measures are greater. This article summarizes existing strategies for controlling modifiable cardiovascular risk factors in primary prevention. The physician can rely on an interprofessional network of cardiovascular prevention. Managing risk factors while respecting the autonomy and priorities of the patient will bring the greatest benefit.
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
October 2002,
BMJ (Clinical research ed.),
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
December 2016,
Minerva endocrinologica,
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
October 2004,
Heart (British Cardiac Society),
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
August 2017,
Expert opinion on pharmacotherapy,
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
June 1988,
Journal of consulting and clinical psychology,
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
July 2008,
Circulation,
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
February 2003,
American journal of preventive medicine,
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
May 2020,
Heart (British Cardiac Society),
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
February 2020,
Journal of clinical hypertension (Greenwich, Conn.),
Vincent Gabus, and
Grégoire Wuerzner, and
Mathieu Saubade, and
Lucie Favre, and
Isabelle Jacot Sadowski, and
David Nanchen
December 2007,
Nature clinical practice. Cardiovascular medicine,
